| Name
|
ANP (1-28), human
|
| Code
|
|
| The alias
|
ANP (1-28), human
|
| Sequence (single letter abbreviation)
|
SLRRSSCFGGRMDRIGAQSGLGCNSFRY (C7&C23 bridge)
|
| Sequence (three-letter abbreviation)
|
H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (trifluoroacetate salt)(Cys7 and 23 bridge)
|
| A basic description
|
Atriopeptin is synthesized primarily in cardiac atria, acts in opposition to angiotensin II. When blood volume overload, Atriopeptin is released to act at the nephron to increase salt and water excretion, lowering blood volume and blood pressure.
|
| solubility
|
|
| The molecular weight
|
3080.5
|
| Chemical formula
|
C127H203N45O39S3
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
N. Chino et al., Peptide Chemistry, 1984, 241, (1985)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Cys7 and 23 bridge)
|